About Community Pharmacy South Central
Continuously improving the quality of care we give patients and improving the outcomes of their treatment is the core purpose of the new NHS commissioning system.
The latest news
Information on training events and resources available for you and your team
Written by admin on Wednesday 18th October 2017
Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly
RPS Scotland is delighted to have been a co-signatory alongside the Chief Pharmaceutical Officer, GPhC, CPS, the Directors of Pharmacy and the National Pharmacy Technicians Group on a letter to all ph
Intrapharm Laboratories Ltd are recalling a specified batch of Mydrilate 0.5 % Eye Drops 5ml as a precautionary measure due to out of specification results for related substances obtained during stabi
NHS England has written to the vaccine system to set out the steps needed to support the significant acceleration of the vaccine programme. You can find a copy of this letter here. The letter include
During the pandemic many pharmacy teams have reported an increase in abuse, violence and aggression from some members of the public. RPS has consistently highlighted abuse as intolerable and condemns
There is one additional product and batch that has been added to this recall. Further information on the affected batches and advice for healthcare professionals can be found on theMHRA website.
Commenting on the increased role for community pharmacies in England in delivering the Covid-19 booster vaccination programme, Chair of the Royal Pharmaceutical Society in England, Ms Thorrun Govind,
There is an error with the patient information leaflet (PIL) that has been provided with Diuril Oral Solution, supplied by Mawdsley-Brooks & Company Limited. Further information and advice for he
There is an error relating to the wording on the outer carton label for Mometasone Furoate 50 Microgram / Dose Nasal Spray, supplied by PilsCo Ltd. Further information and advice for healthcare profe
Specific batches of products are recalled by the Marketing Authorisation Holders and parallel distributor companies as a precautionary measure due to contamination with an impurity called 5-(4’-
The UK Health Security Agency’s Chief Medical Adviser, National Medical Director of NHS England, and Chief Nursing Officer for England have issued an update on COVID-19 Omicron Variant (B.1.1.52
